HLB Therapeutics Co.,Ltd. (115450.KQ)
KRW 10680.0
(-2.11%)
KRW 10680.0
(-2.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 53.74 Billion | 42.4 Billion | 43.58 Billion | 42.92 Billion | 58.96 Billion | 43.58 Billion |
| Cost of Revenue | 47.05 Billion | 34.4 Billion | 38.96 Billion | 36.84 Billion | 53.92 Billion | 38.38 Billion |
| Gross Profit | 6.69 Billion | 7.99 Billion | 4.61 Billion | 6.08 Billion | 5.04 Billion | 5.19 Billion |
| Operating Expenses | 16.16 Billion | 15.5 Billion | 15.7 Billion | 17.35 Billion | 16.92 Billion | 8.35 Billion |
| Selling, General and Administrative Expenses | 15.31 Billion | 15.16 Billion | 10.16 Billion | 13.27 Billion | 13.51 Billion | 5.74 Billion |
| Research and Development Expenses | - | 63.35 Million | 5.3 Billion | 3.85 Billion | 3.06 Billion | 2.47 Billion |
| Other Expenses | - | -273.1 Million | -240.03 Million | -218.65 Million | -350.27 Million | -142.75 Million |
| Cost and Expenses | 62.44 Billion | 49.9 Billion | 54.67 Billion | 54.19 Billion | 70.84 Billion | 46.74 Billion |
| Operating Income | -8.7 Billion | -7.5 Billion | -11.08 Billion | -11.26 Billion | -11.88 Billion | -3.15 Billion |
| Interest Expense | 1.11 Billion | 5.14 Billion | 1.16 Billion | 4.25 Billion | 1.87 Billion | 780.32 Million |
| Income Tax Expense | 939.08 Million | -2.1 Billion | -146.63 Million | 410.9 Million | 1 Billion | -210.54 Million |
| Earnings before Tax | -1.36 Billion | -13.45 Billion | -17.34 Billion | -16.49 Billion | -15.41 Billion | 5.23 Billion |
| Net Income | -2.3 Billion | -11.35 Billion | -17.19 Billion | -16.9 Billion | -16.42 Billion | 4.57 Billion |
| Earnings Per Share Basic | -32.12 | -87.60 | -294.20 | -310.14 | -310.33 | 92.50 |
| Earnings Per Share Diluted | -32.12 | -87.60 | -294.20 | -310.14 | -310.33 | 92.50 |
| Weighted Average Shares Outstanding | 71.66 Million | 129.6 Million | 58.45 Million | 54.49 Million | 52.92 Million | 49.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 71.66 Million | 129.6 Million | 58.45 Million | 54.49 Million | 52.92 Million | 49.45 Million |
| Gross Margin | 0.12 | 0.19 | 0.11 | 0.14 | 0.09 | 0.12 |
| EBIT Margin | 0.15 | -0.14 | -0.22 | -0.25 | -0.19 | -0.06 |
| Profit Margin | -0.04 | -0.27 | -0.39 | -0.39 | -0.28 | 0.10 |
| EBITDA | 8.22 Billion | -5.84 Billion | -14.48 Billion | -11.54 Billion | -12.87 Billion | 6.34 Billion |
| Earnings Before Tax Margin | -0.16 | -0.18 | -0.25 | -0.26 | -0.20 | -0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 11.66 Billion | 12.75 Billion | 15.67 Billion | 53.74 Billion | 19.19 Billion | 8.61 Billion |
| Cost of Revenue | 10.7 Billion | 10.76 Billion | 13.93 Billion | 47.05 Billion | 16.53 Billion | 7.54 Billion |
| Gross Profit | 952.43 Million | 1.99 Billion | 1.73 Billion | 6.69 Billion | 2.66 Billion | 1.06 Billion |
| Operating Expenses | 4.15 Billion | 4.62 Billion | 4.3 Billion | 15.53 Billion | 5.03 Billion | 3.69 Billion |
| Selling, General and Administrative Expenses | 4.06 Billion | 4.52 Billion | 4.31 Billion | - | 4.92 Billion | 3.59 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -95.6 Million | -99.46 Million | 7.29 Million | -185.18 Million | -111.58 Million | -99.43 Million |
| Cost and Expenses | 14.86 Billion | 15.38 Billion | 18.24 Billion | 62.59 Billion | 21.56 Billion | 11.23 Billion |
| Operating Income | -3.2 Billion | -2.63 Billion | -2.57 Billion | -8.84 Billion | -2.37 Billion | -2.62 Billion |
| Interest Expense | 665.35 Million | 365.1 Million | 271.32 Million | 1.11 Billion | 355.66 Million | 236.88 Million |
| Income Tax Expense | 404.71 Million | -130.52 Million | 2.16 Billion | 939.08 Million | -218.16 Million | -775.3 Million |
| Earnings before Tax | -21.86 Billion | 29.03 Million | -2.01 Billion | -1.36 Billion | -1.21 Billion | 2.41 Billion |
| Net Income | -22.26 Billion | 159.55 Million | -4.17 Billion | -2.3 Billion | -1 Billion | 3.18 Billion |
| Earnings Per Share Basic | -299.01 | 2.13 | -56.68 | - | -13.77 | 43.80 |
| Earnings Per Share Diluted | -299.01 | 2.13 | -56.68 | - | -13.77 | 43.70 |
| Weighted Average Shares Outstanding | 74.47 Million | 75.04 Million | 73.7 Million | 71.66 Million | 72.73 Million | 72.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.47 Million | 75.04 Million | 73.7 Million | 71.66 Million | 72.73 Million | 72.89 Million |
| Gross Margin | 0.08 | 0.16 | 0.11 | 0.12 | 0.14 | 0.12 |
| EBIT Margin | -0.10 | -0.04 | -0.03 | - | -0.01 | 0.15 |
| Profit Margin | -1.91 | 0.01 | -0.27 | -0.04 | -0.05 | 0.37 |
| EBITDA | -1.17 Billion | -549.1 Million | -526.03 Million | - | -211.02 Million | 1.29 Billion |
| Earnings Before Tax Margin | -0.27 | -0.21 | -0.16 | -0.16 | -0.12 | -0.30 |
RIAS-B
AGN
TREEHOUSE
6262
9997
ENX